Nhật Bản cấp phép thuốc điều trị COVID-19 dạng uống vào cuối năm nay
Chính phủ Nhật Bản có thể sẽ đưa thuốc kháng virus Molnupiravir của hãng dược phẩm Merk (Mỹ) vào danh mục các loại thuốc điều trị COVID-19 từ cuối năm nay.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu